Company Filing History:
Years Active: 2013
Title: Diógenes Quintana Vázquez: Innovator in Biomedicine
Introduction
Diógenes Quintana Vázquez is a prominent inventor based in Ciudad de la Habana, Cuba. He has made significant contributions to the field of biomedicine, particularly in the development of vaccines. His innovative work focuses on engineering pertactin variants for vaccine use, which has the potential to enhance immune responses.
Latest Patents
Diógenes holds a patent for "Engineered pertactin variants for vaccine use." This invention involves the engineering of the Pertactin protein (Prn) and its application in bacterial vaccines, specifically acellular vaccines. The engineered Prn molecules incorporate polymorphisms from different strains, inducing immune responses with protective capacity and opsonophagocytic activity that surpass those generated by existing vaccines. This advancement is applicable in both human and veterinary medicine.
Career Highlights
Diógenes is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he continues to push the boundaries of vaccine development. His work is crucial in addressing public health challenges through innovative biotechnological solutions.
Collaborations
Diógenes collaborates with talented coworkers, including Tamara Menendez Medina and Anabel Álvarez Acosta. Their combined expertise contributes to the success of their projects and the advancement of biomedicine.
Conclusion
Diógenes Quintana Vázquez is a key figure in the field of biomedicine, with a focus on vaccine innovation. His work on engineered pertactin variants represents a significant step forward in vaccine technology.